Reduction hepatic venous pressure gradient consequence volume contraction due chronic administration spironolactone patients cirrhosis ascites effect plasma volume contraction administration spironolactone furosemide hepatic venous pressure gradient allocated patients cirrhosis ascites spironolactone group hepatic venous pressure gradient significant contraction plasma volume significant correlations change hepatic venous pressure gradient changes plasma volume systemic hemodynamics significant negative correlation hepatic venous pressure gradient change post-treatment plasma aldosterone levels furosemide group hepatic venous pressure gradient plasma volume data significant reduction hepatic venous pressure gradient chronic administration spironolactone due volume contractions patients cirrhosis ascites 